JHU37152 is a potent and selective DREADD agonist, exhibiting high affinity and efficacy at engineered hM3Dq and hM4Di receptors. It is a key research tool for precise chemogenetic manipulation of neuronal activity in both in vitro cellular assays and in vivo models for neuroscience and behavioral studies.